Albemarle Corporation $ALB Shares Acquired by ING Groep NV

ING Groep NV increased its stake in Albemarle Corporation (NYSE:ALB) by 738.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 66,920 shares of the specialty chemicals company’s stock after buying an additional 58,938 shares during the period. ING Groep NV’s holdings in Albemarle were worth $5,426,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Hantz Financial Services Inc. grew its holdings in Albemarle by 10,050.0% during the 2nd quarter. Hantz Financial Services Inc. now owns 406 shares of the specialty chemicals company’s stock worth $25,000 after acquiring an additional 402 shares in the last quarter. CVA Family Office LLC lifted its position in shares of Albemarle by 7,257.1% during the second quarter. CVA Family Office LLC now owns 515 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 508 shares during the last quarter. Cromwell Holdings LLC lifted its position in shares of Albemarle by 36.8% during the third quarter. Cromwell Holdings LLC now owns 413 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 111 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in Albemarle by 536.7% in the second quarter. EverSource Wealth Advisors LLC now owns 573 shares of the specialty chemicals company’s stock worth $36,000 after purchasing an additional 483 shares in the last quarter. Finally, Physician Wealth Advisors Inc. bought a new stake in Albemarle in the third quarter valued at about $40,000. 92.87% of the stock is currently owned by institutional investors.

Albemarle Trading Down 9.7%

NYSE:ALB opened at $158.47 on Friday. The firm has a market capitalization of $18.65 billion, a P/E ratio of -27.56, a P/E/G ratio of 2.53 and a beta of 1.44. The business has a 50 day simple moving average of $157.34 and a 200 day simple moving average of $114.39. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.51. Albemarle Corporation has a 12-month low of $49.43 and a 12-month high of $195.68.

Albemarle (NYSE:ALB) last issued its earnings results on Wednesday, February 11th. The specialty chemicals company reported ($0.53) earnings per share for the quarter, missing the consensus estimate of ($0.40) by ($0.13). Albemarle had a positive return on equity of 0.40% and a negative net margin of 10.74%.The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.34 billion. During the same period in the prior year, the business earned ($1.09) earnings per share. Albemarle’s quarterly revenue was up 15.9% on a year-over-year basis. Equities research analysts predict that Albemarle Corporation will post -0.04 EPS for the current year.

Analysts Set New Price Targets

ALB has been the topic of several research reports. Bank of America upped their price objective on Albemarle from $118.00 to $167.00 and gave the company a “neutral” rating in a research note on Thursday, January 8th. Zacks Research raised Albemarle from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 12th. JPMorgan Chase & Co. raised their price objective on Albemarle from $80.00 to $195.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft raised shares of Albemarle from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $125.00 to $185.00 in a report on Monday, January 12th. Finally, Royal Bank Of Canada increased their target price on shares of Albemarle from $159.00 to $200.00 and gave the stock an “outperform” rating in a report on Wednesday, January 21st. Three equities research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Albemarle currently has a consensus rating of “Moderate Buy” and an average target price of $163.40.

Albemarle News Roundup

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Revenue beat and strong EV/energy-storage demand: Q4 revenue of $1.43B topped estimates and rose ~16% year-over-year, driven by higher Energy Storage volumes and favorable pricing — a sign that lithium end-market demand remains strong. Read More.
• Positive Sentiment: Analyst support and bullish research: Mizuho raised its price target to $185 (neutral rating) and Rothschild/Redburn published a bullish outlook — both actions underpin upside expectations from some sell-side desks. Read More. Read More.
• Positive Sentiment: Policy tailwind for domestic supply: The House passed H.R.3617 (Securing America’s Critical Minerals Supply Act), which aims to strengthen domestic critical-minerals supply chains — a structural tailwind for lithium producers like Albemarle. Read More.
• Neutral Sentiment: FY2026 revenue guidance lifted/updated: Albemarle provided a FY2026 revenue range of roughly $5.7B–$6.0B, above consensus — this signals management expects continued top-line resilience even if EPS guidance was unclear in early releases. Read More.
• Neutral Sentiment: Idling Kemerton Train 1 to preserve flexibility: Management moved Kemerton Train 1 to care & maintenance to improve financial flexibility and optimize global hydroxide mix — reduces near-term operating exposure but keeps restart optionality. Market sees this as prudent capacity management rather than a structural problem. Read More.
• Negative Sentiment: EPS miss and wider-than-expected quarterly loss: Albemarle reported Q4 EPS of ($0.53) vs. consensus ($0.40), which disappointed investors and weighed on near-term sentiment despite the revenue beat. Read More.
• Negative Sentiment: Immediate market reaction and technical pressure: Coverage and market commentary note the stock fell after earnings as traders booked gains and digested the EPS miss; technical indicators show short‑term momentum fatigue, adding to selling pressure. Read More. Read More.

Albemarle Profile

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.